Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus

Publication | Open Access

DOI Full Paper Access

Citations

References

2023

Year

Nancy Hernandez, Wojciech Jankowski, Rahel Frick, Simon Kelow, Joseph H. Lubin, Vijaya L. Simhadri, Jared Adolf‐Bryfogle, Sagar D. Khare, Roland L. Dunbrack, Jeffrey J. Gray,

Heliyon